Cellebrite DI Ltd.
CLBT
$15.81
-$0.19-1.19%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Net Income | -- | -103.33M | -111.87M | -81.10M | |
| Total Depreciation and Amortization | -- | 10.25M | 10.24M | 10.01M | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -- | 173.34M | 173.21M | 134.63M | |
| Change in Net Operating Assets | -- | 17.30M | 28.04M | 38.52M | |
| Cash from Operations | -- | 97.56M | 99.62M | 102.06M | |
| Capital Expenditure | -- | -6.91M | -5.66M | -5.23M | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -115.68M | -94.41M | -17.31M | |
| Cash from Investing | -- | -122.59M | -100.07M | -22.54M | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | -- | 21.74M | 24.10M | 21.77M | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | -- | 21.74M | 24.10M | 21.77M | |
| Foreign Exchange rate Adjustments | -- | -252.00K | -196.00K | 589.00K | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -- | -3.55M | 23.46M | 101.87M | |